Document Type : Original Article

Authors

1 Jarallah German Specialized Clinic

2 Personalized Medicine Research Center of AmitisGen, Tehran, Iran

Abstract

 
Cervical cancer is a common and deadly cancer among women around the world. One of the genes associated with many cancers is the CYP1B1gene.Some studies have shown that polymorphisms in the CYP1B1 gene can induce hyper activation of proteins and increase the incidence of several cancers. In the present study, we examined the association between the CYP1B1 C4326G polymorphism and the risk of cervical cancer.60 newly diagnosed patients with cervical cancer and 60 cancers-free controls.DNA was extracted by Salting-out method, Restriction fragment length polymorphism PCR was employed to determine the genotype of the CYP1B1 C4326G polymorphisms. the frequencies of the three genotypes (CC, CG, and GG) of CYP1B1 C4326G in cervical cancer cases and controls were 68.0, 25.4, 6.6%and 73.1, 21.4, and 5.5 %, respectively, and there was a significant difference between the two groups (χ2=7.41, P=0.02).  
 


Cervical cancer,CYP1B1, RFLP-PCR, Human papilloma virus

Keywords

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 
Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Schoell WMJ, Janicek MF, Mirhashemi R. Epidemiology and 
biology of cervical cancer. Semin Surg Oncol. 1999;16:203–11.
3. Berumen-Campos J. Human papillomavirus and cervical cancer. Gac Med Mex. 2006;142:51–9.
4. Franceschi S. The IARC commitment to cancer prevention: the 
example of papillomavirus and cervical cancer. Recent Results 
Cancer Res. 2005;166:277–97.
5. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.
6. Paracchini V, Raimondi S, Gram IT, et al. Meta- and pooled 
analyses of the cytochrome P-450 1B1 Val432Leu polymorphism 
and breast cancer: a HuGE-GSEC review. Am J Epidemiol. 
2007;165:115–25.
7. Hayes CL, Spink DC, Spink BC, et al. Seventeen beta-estradiol 
hydroxylation catalyzed by human cytochrome P450 1B1. Proc 
Natl Acad Sci USA. 1996;93:9776–81.8. Shah PP, Singh AP, Singh M, et al. Association of functionally 
important polymorphisms in cytochrome P4501B1 with lung cancer. Mutat Res. 2008;643:4–10.
9. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya 
R. CYP1B1 gene in endometrial cancer. Mol Cell Endocrinol. 
2003;202:171–6.
10. Meyer UA, Gut J, Kronbach T, et al. The molecular mechanisms 
of two common polymorphisms of drug oxidation evidence for 
functional changes in cytochrome P-450 isozymes catalyzing bufuralol and mephenytoin oxidation. Xenobiotica. 1986;16:449–64.
11. Tang YM, Wo Y-YP, Stewart J, et al. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J BiolChem. 1996;271:28324–30.
12. Stoilov I, Akarsu AN, Alozie I, et al. Sequence analysis and 
homology modeling suggest that primary congenital glaucoma on 
2p21 results from mutations disrupting either the hinge region or 
the conserved core structures of cytochrome P4501B1. Am J Hum 
Genet. 1998;62:573–84.
13. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of 
polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000;60:3440–4.
14. Li DN, Seidel A, Pritchard MP, et al. Polymorphisms in P450 
CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics. 
2000;10:343–53.